Glucose Metabolism Disorders

• Site n°12 — Banja Luka, Bosnia and Herzegovina
• Site n°11 — Sarajevo, Bosnia and Herzegovina
• Site n°22 — Riga, Latvia
• Site n°21 — Riga, Latvia

• Padova, Italy
• Pisa, Italy

• Lipidklinikken, Rikshospitalet — Oslo, Norway

• Pfizer Investigational Site — Chula Vista, California, United States
• Pfizer Investigational Site — Fountain Valley, California, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — San Antonio, Texas, United States

• Bretten, Baden-Wurttemberg, Germany
• Deggingen, Baden-Wurttemberg, Germany
• Dettenheim, Baden-Wurttemberg, Germany
• Künzelsau, Baden-Wurttemberg, Germany

• Schwetzingen, Baden-Wurttemberg, Germany
• Wiesbaden, Hesse, Germany
• Bottrop, North Rhine-Westphalia, Germany
• Düsseldorf, North Rhine-Westphalia, Germany

• Lichtenfels, Bavaria, Germany
• Hamburg, Free and Hanseatic City of Hamburg, Germany
• Frankfurt am Main, Hesse, Germany
• Kassel, Hesse, Germany

• Pfizer Investigational Site — New Haven, Connecticut, United States

Not specified

• Villingen-Schwenningen, Baden-Wurttemberg, Germany
• Aschaffenburg, Bavaria, Germany
• Ingolstadt, Bavaria, Germany
• Frankfurt am Main, Hesse, Germany